Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin a and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage

Vaccine

Volumn 24, Issue 1, 2006, Pages 57-65

  Holmlund, Emma ^a   Quiambao, Beatriz ^b   Ollgren, Jukka ^a   Nohynek, Hanna ^a   Käyhty, Helena ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

Author keywords

Maternal antibodies; Pneumococcal carriage; Pneumococcal protein antibodies; Streptococcus pneumoniae

Indexed keywords

ANTIBODY; BACTERIAL PROTEIN; MATERNAL ANTIBODY; PNEUMOCOCCAL SURFACE ADHESIN A; PNEUMOCOCCAL SURFACE PROTEIN A; PNEUMOCOCCUS VACCINE; PNEUMOLYSIN; UNCLASSIFIED DRUG;

AGE; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; FILIPINO; HUMAN; IMMUNOASSAY; INFANT; MOTHER CHILD RELATION; PREGNANT WOMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; UMBILICAL CORD BLOOD;

ADHESINS, BACTERIAL; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; FEMALE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; NASOPHARYNX; PNEUMOCOCCAL VACCINES; PREGNANCY; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 28344441389     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.055     Document Type: Article

References (42)

1. S. Rapola, V. Jäntti, R. Haikala, R. Syrjänen, G. Carlone, and J.S. Sampson Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media J Infect Dis 182 4 2000 1146 1152
2. A. Soininen, H. Pursiainen, T. Kilpi, and H. Käyhty Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children J Infect Dis 184 5 2001 569 576
3. S. Black, H. Shinefield, B. Fireman, E. Lewis, P. Ray, and J.R. Hansen Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group Pediatr Infect Dis J 19 3 2000 187 195
4. S. Rapola, T. Kilpi, M. Lahdenkari, A.K. Takala, P.H. Mäkela, and H. Käyhty Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media? J Infect Dis 184 5 2001 577 581
5. J.C. Butler, E.D. Shapiro, and G.M. Carlone Pneumococcal vaccines: history, current status, and future directions Am J Med 107 1A 1999 69S 76S
6. R.M. Douglas, J.C. Paton, S.J. Duncan, and D.J. Hansman Antibody response to pneumococcal vaccination in children younger than five years of age J Infect Dis 148 1 1983 131 137
7. D. Scheifele, S. Halperin, L. Pelletier, and J. Talbot Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT) Clin Infect Dis 31 1 2000 58 64
8. J. Eskola, T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, and E. Herva Efficacy of a pneumococcal conjugate vaccine against acute otitis media N Engl J Med 344 6 2001 403 409
9. T.J. Coffey, M.C. Enright, M. Daniels, J.K. Morona, R. Morona, and W. Hryniewicz Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae Mol Microbiol 27 1 1998 73 83
10. N. Mbelle, R.E. Huebner, A.D. Wasas, A. Kimura, I. Chang, and K.P. Klugman Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine J Infect Dis 180 4 1999 1171 1176
11. W.P. Hausdorff, J. Bryant, P.R. Paradiso, and G.R. Siber Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I Clin Infect Dis 30 1 2000 100 121
12. T. Camou, R. Palacio, J.L. Di Fabio, and M. Hortal Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations Vaccine 21 17-18 2003 2093 2096
13. M.J. Crain, W.D. Waltman 2nd, J.S. Turner, J. Yother, D.F. Talkington, and L.S. McDaniel Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae Infect Immun 58 10 1990 3293 3299
14. K.E. Morrison, D. Lake, J. Crook, G. Carlone, E. Ades, and R. Facklam Confirmation of psaA in all 90 serotypes of Streptococcus pneumoniae by PCR and potential of this assay for identification and diagnosis J Clin Microbiol 38 1 2000 434 437
15. R.C. Tart, L.S. McDaniel, B.A. Ralph, and D.E. Briles Truncated Streptococcus pneumoniae PspA molecules elicit cross- protective immunity against pneumococcal challenge in mice J Infect Dis 173 2 1996 380 386
16. D.E. Briles, E. Ades, J.C. Paton, J.S. Sampson, G. Carlone, and R.C. Huebner Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae Infect Immun 68 2 2000 796 800
17. A.D. Ogunniyi, R.L. Folland, D.E. Briles, S.K. Hollingshead, and J.C. Paton Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae Infect Immun 68 5 2000 3028 3033
18. G.S. Nabors, P.A. Braun, D.J. Herrmann, M.L. Heise, D.J. Pyle, and S. Gravenstein Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules Vaccine 18 17 2000 1743 1754
19. D.F. Talkington, B.G. Brown, J.A. Tharpe, A. Koenig, and H. Russell Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA) Microb Pathog 21 1 1996 17 22
20. J.C. Paton, R.A. Lock, C.J. Lee, J.P. Li, A.M. Berry, and T.J. Mitchell Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide Infect Immun 59 7 1991 2297 2304
21. T.J. Mitchell, P.W. Andrew, G.J. Boulnois, C.J. Lee, R.A. Lock, and J.C. Paton Molecular studies of pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae as an aid to vaccine design Zentralbl Bakteriol Suppl. 23 1992 429 438
22. J.E. Alexander, R.A. Lock, C.C. Peeters, J. Poolman, P.W. Andrew, and T.J. Mitchell Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae Infect Immun 62 12 1994 5683 5688
23. B. Simell, M. Korkeila, H. Pursiainen, T.M. Kilpi, and H. Käyhty Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein A in children J Infect Dis 183 6 2001 887 896
24. B.P. Quiambao, H. Nohynek, H. Käyhty, J. Ollgren, L. Gozum, and C.P. Gepanayao Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines Vaccine 21 24 2003 3451 3454
25. L.S. McDaniel, B.A. Ralph, D.O. McDaniel, and D.E. Briles Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260 Microb Pathog 17 5 1994 323 337
26. P.A. Pilling, M.C. Lawrence, A.M. Berry, A.D. Ogunniyi, R.A. Lock, and J.C. Paton Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal-transporter protein of Streptococcus pneumoniae Acta Crystallogr D Biol Crystallogr 54 Pt 6 Pt 2 1998 1464 1466
27. C. Laine, T. Mwangi, C.M. Thompson, J. Obiero, M. Lipsitch, and J.A. Scott Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya Infect Immun 72 6 2004 3331 3335
28. L. Baril, D.E. Briles, P. Crozier, J.D. King, S.K. Hollingshead, and T.F. Murphy Natural materno-fetal transfer of antibodies to PspA and to PsaA Clin Exp Immunol 135 3 2004 474 477
29. T. Leino, K. Auranen, J. Jokinen, M. Leinonen, P. Tervonen, and A.K. Takala Pneumococcal carriage in children during their first two years: important role of family exposure Pediatr Infect Dis J 20 11 2001 1022 1027
30. V.O. Rotimi, and B.I. Duerden The development of the bacterial flora in normal neonates J Med Microbiol 14 1 1981 51 62
31. A. Virolainen, W. Russell, M.J. Crain, S. Rapola, H. Käyhty, and D.E. Briles Human antibodies to pneumococcal surface protein A in health and disease Pediatr Infect Dis J 19 2 2000 134 138
32. Riddell AF, Sleeman K, Crook D, Day, N, Moore, C, Peto, T, et al. Age specific sero-epidemiology of anti-pneumococcal PspA antibodies. In: 3rd International Symposium on Pneumococci and Pneumococcal Diseases, Anchorage, Alaska, USA, 2002.
33. H. Roche, A. Håkansson, S.K. Hollingshead, and D.E. Briles Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model Infect Immun 71 3 2003 1033 1041
34. Melin M, Hollingshead SK, Briles DE, Kaijalainen TH, Kilpi T, Käyhty H. Development of Family-specific Antibodies to Pneumococcal Surface Protein A (PspA) in Relation to Pneumococcal (Pnc) Contacts. In: 4th International Symposium on Pneumococci and Pneumococcal Diseases [Abstract IMM-40], Helsinki, Finland, 2004.
35. Lindell E, van den Dobbelsteen G, Quiambao BP, Nohynek H, Käyhty H. Natural development and functional activity of pneumococcal pneumlysin antibodies in Filipino infants and mothers. In: 3rd International Symposium on Pneumococci and Pneumococcal Diseases, Anchorage, Alaska, USA, 2002.
36. D.M. Musher, H.M. Phan, and R.E. Baughn Protection against bacteremic pneumococcal infection by antibody to pneumolysin J Infect Dis 183 5 2001 827 830
37. N.S. Shahid, M.C. Steinhoff, S.S. Hoque, T. Begum, C. Thompson, and G.R. Siber Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine Lancet 346 8985 1995 1252 1257
38. H. Sarvas, I. Seppala, S. Kurikka, R. Siegberg, and O. Mäkela Half-life of the maternal IgG1 allotype in infants J Clin Immunol 13 2 1993 145 151
39. T.L. McCool, T.R. Cate, G. Moy, and J.N. Weiser The immune response to pneumococcal proteins during experimental human carriage J Exp Med 195 3 2002 359 365
40. D.E. Briles, S.K. Hollingshead, J.C. Paton, E.W. Ades, L. Novak, and F.W. Van Ginkel Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae J Infect Dis 188 3 2003 339 348
41. Holmlund E, Jaakkola T, Saarinen L, Lahdenkari, M, Hamel, J, Kilpi, T, et al. Serum antibodies to the pneumococcal surface proteins BVH-3 and BVH-11 in Finnish infants and adults. In: 4th International Symposium on Pneumococci and Pneumococcal Diseases [Abstract IMM-26], Helsinki, Finland, 2004.
42. Adrian PV, Bogaert D, Holmlund E, Saarinen, L, Lahdenkari, de Groot, R, et al. Development of antibodies against the putative proteinase maturation protein A (PpmA) in relation to pneumococcal carriage and otitis media. In: 4th International Symposium on Pneumococci and Pneumococcal Diseases [Abstract IMM-11], Helsinki, Finland, 2004.